Amrize AG (SWX:AMRZ)
40.05
-0.02 (-0.05%)
Jul 9, 2026, 5:31 PM CET
Amrize AG Revenue
Amrize AG had revenue of $2.18B USD in the quarter ending March 31, 2026, with 4.66% growth. This brings the company's revenue in the last twelve months to $11.91B, up 2.52% year-over-year. In the year 2025, Amrize AG had annual revenue of $11.82B with 0.95% growth.
Revenue (ttm)
$11.91B
Revenue Growth
+2.52%
P/S Ratio
2.32
Revenue / Employee
$626.95K
Employees
19,000
Market Cap
22.17B CHF
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 11.82B | 111.00M | 0.95% |
| Dec 31, 2024 | 11.70B | 27.00M | 0.23% |
| Dec 31, 2023 | 11.68B | 951.00M | 8.87% |
| Dec 31, 2022 | 10.73B | 2.59B | 31.90% |
| Dec 31, 2021 | 8.13B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Holcim AG | 15.72B |
| Sika AG | 11.20B |
| Givaudan | 7.47B |
| Clariant AG | 3.92B |
| EMS-CHEMIE HOLDING AG | 1.97B |
| Dottikon ES Holding AG | 439.92M |
| CPH Group AG | 334.06M |
| Gurit Holding AG | 319.57M |
Amrize AG News
- 1 day ago - Amrize price target raised to CHF 56.60 from CHF 54.80 at JPMorgan - TheFly
- 1 day ago - Amrize price target lowered to $58 from $65 at Wells Fargo - TheFly
- 2 days ago - Amrize downgraded to Hold from Buy at Truist - TheFly
- 13 days ago - Amrize price target raised to CHF 54 from CHF 52 at Deutsche Bank - TheFly
- 17 days ago - Amrize price target lowered to $63 from $65 at Morgan Stanley - TheFly
- 20 days ago - Amrize to Modernize Montreal Area Cement Plant to be Most Advanced in Eastern Canada - Business Wire
- 6 weeks ago - Insider Buying: Nollaig Forrest Acquires Shares in Amrize Ltd (AMRZ) - GuruFocus
- 6 weeks ago - Insider Buying: Roald Brouwer Acquires Additional Shares of Amrize Ltd (AMRZ) - GuruFocus